Frontlight ResearchEarly access
Prostate cancer trials, also abroad
1,592 open Prostate cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) has 5 sites in Switzerland and runs in 35 countries. If a site near you is full, another one may still take people.
See A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) in all 35 countries